Iodine in PDB 4bsv: Heterodimeric Fc Antibody Azymetric Variant 1
Protein crystallography data
The structure of Heterodimeric Fc Antibody Azymetric Variant 1, PDB code: 4bsv
was solved by
M.D.L.Suits,
T.Spreter,
E.E.Cabrera,
S.B.Dixit,
P.I.Lario,
D.K.Y.Poon,
I.E.P.D'angelo,
M.J.Boulanger,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
41.38 /
1.75
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
49.540,
74.920,
148.920,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
17.767 /
20.821
|
Iodine Binding Sites:
The binding sites of Iodine atom in the Heterodimeric Fc Antibody Azymetric Variant 1
(pdb code 4bsv). This binding sites where shown within
5.0 Angstroms radius around Iodine atom.
In total 4 binding sites of Iodine where determined in the
Heterodimeric Fc Antibody Azymetric Variant 1, PDB code: 4bsv:
Jump to Iodine binding site number:
1;
2;
3;
4;
Iodine binding site 1 out
of 4 in 4bsv
Go back to
Iodine Binding Sites List in 4bsv
Iodine binding site 1 out
of 4 in the Heterodimeric Fc Antibody Azymetric Variant 1
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 1 of Heterodimeric Fc Antibody Azymetric Variant 1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:I1460
b:18.3
occ:0.50
|
I
|
B:IOD1461
|
0.0
|
17.9
|
0.5
|
OG
|
B:SER254
|
3.5
|
21.2
|
0.5
|
O
|
B:HOH2018
|
3.5
|
19.9
|
0.5
|
OG
|
B:SER254
|
3.6
|
21.3
|
0.5
|
N
|
B:SER254
|
3.9
|
18.8
|
0.5
|
CB
|
B:SER254
|
3.9
|
19.7
|
0.5
|
CB
|
B:SER254
|
4.0
|
18.8
|
0.5
|
N
|
B:SER254
|
4.0
|
18.1
|
0.5
|
N
|
B:ILE253
|
4.0
|
15.6
|
0.5
|
CB
|
B:MET252
|
4.0
|
16.2
|
0.5
|
CB
|
B:MET252
|
4.0
|
16.8
|
0.5
|
CG2
|
B:ILE253
|
4.0
|
19.2
|
0.5
|
N
|
B:ILE253
|
4.0
|
15.7
|
0.5
|
O
|
B:HOH2015
|
4.0
|
19.1
|
0.5
|
SD
|
B:MET252
|
4.2
|
24.2
|
0.5
|
CA
|
B:MET252
|
4.3
|
16.2
|
0.5
|
CA
|
B:MET252
|
4.3
|
16.4
|
0.5
|
O
|
B:HOH2229
|
4.3
|
48.5
|
0.5
|
SD
|
B:MET252
|
4.3
|
22.1
|
0.5
|
C
|
B:MET252
|
4.3
|
15.8
|
0.5
|
CG2
|
B:ILE253
|
4.4
|
18.2
|
0.5
|
C
|
B:MET252
|
4.4
|
15.6
|
0.5
|
CA
|
B:SER254
|
4.5
|
19.4
|
0.5
|
CG
|
B:MET252
|
4.6
|
16.5
|
0.5
|
CA
|
B:SER254
|
4.6
|
18.0
|
0.5
|
CG
|
B:MET252
|
4.7
|
19.0
|
0.5
|
C
|
B:ILE253
|
4.8
|
17.6
|
0.5
|
CA
|
B:ILE253
|
4.8
|
17.5
|
0.5
|
CA
|
B:ILE253
|
4.8
|
17.8
|
0.5
|
C
|
B:ILE253
|
4.9
|
17.2
|
0.5
|
CB
|
B:ILE253
|
5.0
|
17.4
|
0.5
|
|
Iodine binding site 2 out
of 4 in 4bsv
Go back to
Iodine Binding Sites List in 4bsv
Iodine binding site 2 out
of 4 in the Heterodimeric Fc Antibody Azymetric Variant 1
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 2 of Heterodimeric Fc Antibody Azymetric Variant 1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:I1461
b:17.9
occ:0.50
|
I
|
B:IOD1460
|
0.0
|
18.3
|
0.5
|
OG
|
B:SER254
|
3.5
|
21.2
|
0.5
|
O
|
B:HOH2018
|
3.5
|
19.9
|
0.5
|
OG
|
B:SER254
|
3.6
|
21.3
|
0.5
|
N
|
B:SER254
|
3.9
|
18.8
|
0.5
|
CB
|
B:SER254
|
3.9
|
19.7
|
0.5
|
CB
|
B:SER254
|
3.9
|
18.8
|
0.5
|
N
|
B:SER254
|
3.9
|
18.1
|
0.5
|
N
|
B:ILE253
|
4.0
|
15.6
|
0.5
|
CB
|
B:MET252
|
4.0
|
16.2
|
0.5
|
CB
|
B:MET252
|
4.0
|
16.8
|
0.5
|
N
|
B:ILE253
|
4.0
|
15.7
|
0.5
|
CG2
|
B:ILE253
|
4.0
|
19.2
|
0.5
|
O
|
B:HOH2015
|
4.0
|
19.1
|
0.5
|
SD
|
B:MET252
|
4.2
|
24.2
|
0.5
|
CA
|
B:MET252
|
4.3
|
16.2
|
0.5
|
CA
|
B:MET252
|
4.3
|
16.4
|
0.5
|
C
|
B:MET252
|
4.3
|
15.8
|
0.5
|
O
|
B:HOH2229
|
4.3
|
48.5
|
0.5
|
SD
|
B:MET252
|
4.3
|
22.1
|
0.5
|
CG2
|
B:ILE253
|
4.3
|
18.2
|
0.5
|
C
|
B:MET252
|
4.4
|
15.6
|
0.5
|
CA
|
B:SER254
|
4.5
|
19.4
|
0.5
|
CG
|
B:MET252
|
4.6
|
16.5
|
0.5
|
CA
|
B:SER254
|
4.6
|
18.0
|
0.5
|
CG
|
B:MET252
|
4.7
|
19.0
|
0.5
|
C
|
B:ILE253
|
4.8
|
17.6
|
0.5
|
CA
|
B:ILE253
|
4.8
|
17.5
|
0.5
|
CA
|
B:ILE253
|
4.8
|
17.8
|
0.5
|
C
|
B:ILE253
|
4.9
|
17.2
|
0.5
|
CB
|
B:ILE253
|
5.0
|
17.4
|
0.5
|
|
Iodine binding site 3 out
of 4 in 4bsv
Go back to
Iodine Binding Sites List in 4bsv
Iodine binding site 3 out
of 4 in the Heterodimeric Fc Antibody Azymetric Variant 1
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 3 of Heterodimeric Fc Antibody Azymetric Variant 1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:I1462
b:23.3
occ:0.50
|
I
|
B:IOD1462
|
0.0
|
23.3
|
0.5
|
I
|
B:IOD1462
|
0.1
|
23.5
|
0.5
|
O
|
B:HOH2169
|
3.3
|
22.4
|
0.5
|
O
|
B:HOH2162
|
3.4
|
14.7
|
0.5
|
O
|
B:HOH4125
|
3.5
|
21.1
|
0.5
|
CA
|
B:GLY385
|
3.9
|
25.5
|
0.5
|
O
|
B:HOH4119
|
4.0
|
14.9
|
0.5
|
CG
|
B:GLU382
|
4.1
|
15.1
|
0.5
|
O
|
B:HOH2214
|
4.1
|
14.2
|
0.5
|
CA
|
B:GLY385
|
4.1
|
24.5
|
0.5
|
CG
|
B:GLU382
|
4.2
|
19.4
|
0.5
|
C
|
B:GLY385
|
4.3
|
23.9
|
0.5
|
C
|
B:GLY385
|
4.4
|
25.4
|
0.5
|
O
|
B:HOH4118
|
4.4
|
17.4
|
0.5
|
O
|
B:GLY385
|
4.4
|
29.4
|
0.5
|
CB
|
B:GLU382
|
4.5
|
14.7
|
0.5
|
N
|
B:GLY385
|
4.6
|
23.2
|
0.5
|
CB
|
B:GLU382
|
4.6
|
17.6
|
0.5
|
OE1
|
B:GLU382
|
4.6
|
16.0
|
0.5
|
O
|
B:GLY385
|
4.7
|
30.3
|
0.5
|
CD
|
B:GLU382
|
4.7
|
15.3
|
0.5
|
N
|
B:GLY385
|
4.7
|
23.7
|
0.5
|
CD
|
B:GLU382
|
4.8
|
21.1
|
0.5
|
N
|
B:GLN386
|
4.9
|
22.5
|
0.5
|
OE2
|
B:GLU382
|
4.9
|
22.3
|
0.5
|
O
|
B:HOH2160
|
4.9
|
21.2
|
0.5
|
N
|
B:GLN386
|
5.0
|
25.1
|
0.5
|
|
Iodine binding site 4 out
of 4 in 4bsv
Go back to
Iodine Binding Sites List in 4bsv
Iodine binding site 4 out
of 4 in the Heterodimeric Fc Antibody Azymetric Variant 1
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 4 of Heterodimeric Fc Antibody Azymetric Variant 1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:I1462
b:23.5
occ:0.50
|
I
|
B:IOD1462
|
0.0
|
23.5
|
0.5
|
I
|
B:IOD1462
|
0.1
|
23.3
|
0.5
|
O
|
B:HOH2162
|
3.4
|
14.7
|
0.5
|
O
|
B:HOH2169
|
3.4
|
22.4
|
0.5
|
O
|
B:HOH4125
|
3.7
|
21.1
|
0.5
|
O
|
B:HOH4119
|
4.0
|
14.9
|
0.5
|
CA
|
B:GLY385
|
4.0
|
25.5
|
0.5
|
O
|
B:HOH2214
|
4.0
|
14.2
|
0.5
|
CG
|
B:GLU382
|
4.1
|
15.1
|
0.5
|
CA
|
B:GLY385
|
4.2
|
24.5
|
0.5
|
CG
|
B:GLU382
|
4.2
|
19.4
|
0.5
|
C
|
B:GLY385
|
4.4
|
23.9
|
0.5
|
O
|
B:HOH4118
|
4.5
|
17.4
|
0.5
|
C
|
B:GLY385
|
4.5
|
25.4
|
0.5
|
CB
|
B:GLU382
|
4.6
|
14.7
|
0.5
|
O
|
B:GLY385
|
4.6
|
29.4
|
0.5
|
N
|
B:GLY385
|
4.6
|
23.2
|
0.5
|
OE1
|
B:GLU382
|
4.7
|
16.0
|
0.5
|
CB
|
B:GLU382
|
4.7
|
17.6
|
0.5
|
CD
|
B:GLU382
|
4.7
|
15.3
|
0.5
|
N
|
B:GLY385
|
4.8
|
23.7
|
0.5
|
CD
|
B:GLU382
|
4.8
|
21.1
|
0.5
|
O
|
B:GLY385
|
4.8
|
30.3
|
0.5
|
OE2
|
B:GLU382
|
4.9
|
22.3
|
0.5
|
|
Reference:
T.S.Von Kreudenstein,
E.Escobar-Carbrera,
P.I.Lario,
I.D'angelo,
K.Brault,
J.Kelly,
Y.Durocher,
J.Baardsnes,
R.J.Woods,
M.H.Xie,
P.Girod,
M.D.L.Suits,
M.J.Boulanger,
D.K.Y.Poon,
G.Y.K.Ng,
S.B.Dixit.
Improving Biophysical Properties of A Bispecific Antibody Scaffold to Aid Developability: Quality By Molecular Design. Mabs V. 5 646 2013.
ISSN: ISSN 1942-0862
PubMed: 23924797
DOI: 10.4161/MABS.25632
Page generated: Sun Aug 11 17:26:34 2024
|